This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (81)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Shlomo Bar-Sela, MD; Michael Ehrenfeld, MD; Marcel Eliakim, MD

Arch Intern Med. 1981;141(9):1191-1192.

Abstract
• The incidence of atrial fibrillation (AF) in 142 patients with thyrotoxicosis was 21% and that of thromboembolic disease was 8.5%. Male sex, increasing age, and associated rheumatic or hypertensive heart disease were significantly associated with the presence of AF. Thromboembolic episodes occurred in 12 (40%) of the patients with AF and in none of the 112 patients without AF. Cerebral emboli accounted for 53% of the episodes. In view of the grave prognosis of the embolic episodes, patients with thyrotoxicosis should be treated with heparin during attacks of AF and with oral anticoagulants when they have chronic fibrillation.

(Arch Intern Med 1981;141:1191-1192)

Author Affiliations
From the Department of Medicine A, Hadassah University Hospital, Jerusalem.

Footnotes
Accepted for publication July 17, 1980.

Reprint requests to Department of Medicine A, Hadassah University Hospital, Kiryat Hadassah, Ein Karem, Jerusalem, Israel (Dr Bar-Sela).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Singer et al.
Chest 2008;133:546S-592S.
ABSTRACT | FULL TEXT  

Association Between Serum Free Thyroxine Concentration and Atrial Fibrillation
Gammage et al.
Arch Intern Med 2007;167:928-934.
ABSTRACT | FULL TEXT  

Cardiovascular Manifestations of Hyperthyroidism Before and After Antithyroid Therapy: A Matched Case-Control Study
Osman et al.
J Am Coll Cardiol 2007;49:71-81.
ABSTRACT | FULL TEXT  

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Writing Committee Members et al.
Europace 2006;8:651-745.
FULL TEXT  

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster et al.
J Am Coll Cardiol 2006;48:e149-e246.
FULL TEXT  

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster et al.
Circulation 2006;114:e257-e354.
FULL TEXT  

Thyroid hormone in health and disease
Boelaert and Franklyn
J Endocrinol 2005;187:1-15.
ABSTRACT | FULL TEXT  

Thyroid Diseases and Cerebrovascular Disease
Squizzato et al.
Stroke 2005;36:2302-2310.
ABSTRACT | FULL TEXT  

Thyroid Hormone Action in the Heart
Kahaly and Dillmann
Endocr. Rev. 2005;26:704-728.
ABSTRACT | FULL TEXT  

Is Thyroid Hormone Suppression Therapy Prothrombotic?
Horne et al.
J. Clin. Endocrinol. Metab. 2004;89:4469-4473.
ABSTRACT | FULL TEXT  

Antithrombotic Therapy in Atrial Fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Singer et al.
Chest 2004;126:429S-456S.
ABSTRACT | FULL TEXT  

Cardiac Dysrhythmias and Thyroid Dysfunction - The Hidden Menace?
Osman et al.
J. Clin. Endocrinol. Metab. 2002;87:963-967.
ABSTRACT | FULL TEXT  

ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology
Fuster et al.
Circulation 2001;104:2118-2150.
FULL TEXT  

Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology
Eur Heart J 2001;22:1852-1923.
 

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary: A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology
Fuster et al.
J Am Coll Cardiol 2001;38:1231-1265.
FULL TEXT  

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology
Fuster et al.
J Am Coll Cardiol 2001;38:1266-1266.
FULL TEXT  

Antithrombotic Therapy in Atrial Fibrillation
Albers et al.
Chest 2001;119 :194S-206S.
FULL TEXT  

Acute Exacerbation of Masked Hyperthyroidism After Iodine Restriction Followed by Thyrotoxic Atrial Fibrillation and Cerebral Embolism: A Case Report
Kuroda et al.
ANGIOLOGY 1996;47:709-712.
ABSTRACT  

Superior Sagittal Sinus Thrombosis and Thyrotoxicosis : Possible Association in Two Cases
Siegert et al.
Stroke 1995;26:496-497.
ABSTRACT | FULL TEXT  

Prevention of embolism in atrial fibrillation
Halperin
Vasc Med 1991;2:111-119.
 

Atrial Fibrillation
Wipf and Lipsky
Arch Intern Med 1990;150:1598-1603.
ABSTRACT  

Cardiogenic Brain Embolism: The Second Report of the Cerebral Embolism Task Force
Arch Neurol 1989;46:727-743.
ABSTRACT  

The Secondary Prevention of Stroke in Patients With Atrial Fibrillation
Sherman et al.
Arch Neurol 1986;43:68-70.
ABSTRACT  

Cardiogenic Brain Embolism
Cerebral Embolism Task Force
Arch Neurol 1986;43:71-84.
ABSTRACT